In inflamed corneal cells, NADPH repletion occurred within 30 minutes, accompanied by ROS suppression and immune-cell ...

The pharmaceutical industry has long operated on a one-size-fits-all model, developing drugs primarily tested on, and thus best suited for, people of European descent. This approach ignores — and ...

A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders such as Alzheimer's disease might also have potential for treating alcohol ...

Bringing a new drug to patients requires more than just identifying a promising candidate. Scientists must rigorously test the compound’s safety, biological activity, and pharmacokinetic properties ...

Forbes contributors publish independent expert analyses and insights. Geri Stengel writes about the success factors of women entrepreneurs. The gender gap in healthcare isn’t just a question of equity ...

Single dose of EDIT-401 achieved ~90% or greater mean reductions in LDL-C, Lp(a), and ApoB in non-human primates ...

LANSING, Mich. (WLNS) — Researchers at Michigan State University have successfully performed CRISPR-based genome editing in Nile grass rats, the first ever successful genome editing in the species.

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating ...

Company to advance additional preclinical studies and pursue government partnership opportunities for bucillamine as a ...

Our faculty-led laboratories investigate a broad range of conditions spanning kidney stone disease, endourologic disorders, and urologic cancers. Research within the department encompasses all stages ...

MAINZ, Germany, April 24, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data for selected assets from its diversified oncology pipeline, including mRNA cancer ...